Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock | Zendy

Rebecca Mathew | Zendy; Pietro Di Santo | Zendy; Richard G. Jung | Zendy; Jeffrey A. Marbach | Zendy; Jordan Hutson | Zendy; Trevor Simard | Zendy; F. Daniel Ramirez | Zendy; David T. Harnett | Zendy; Anas Merdad | Zendy; Aws Almufleh | Zendy; Willy Weng | Zendy; Omar AbdelRazek | Zendy; Shan M. Fernando | Zendy; Kwadwo Kyeremanteng | Zendy; Jordan Bernick | Zendy; George A. Wells | Zendy; Vincent Chan | Zendy; Michael Froeschl | Zendy; Marino Labinaz | Zendy; Michel R. Le May | Zendy; Juan Russo | Zendy; Benjamin Hibbert | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock

Author(s) -

Rebecca Mathew,

Pietro Di Santo,

Richard G. Jung,

Jeffrey A. Marbach,

Jordan Hutson,

Trevor Simard,

F. Daniel Ramirez,

David T. Harnett,

Anas Merdad,

Aws Almufleh,

Willy Weng,

Omar AbdelRazek,

Shan M. Fernando,

Kwadwo Kyeremanteng,

Jordan Bernick,

George A. Wells,

Vincent Chan,

Michael Froeschl,

Marino Labinaz,

Michel R. Le May,

Juan Russo,

Benjamin Hibbert

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2026845

Subject(s) - cardiogenic shock , milrinone , inotrope , dobutamine , medicine , cardiology , shock (circulatory) , intensive care medicine , myocardial infarction , hemodynamics

Cardiogenic shock is associated with substantial morbidity and mortality. Although inotropic support is a mainstay of medical therapy for cardiogenic shock, little evidence exists to guide the selection of inotropic agents in clinical practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research